Eledon Pharmaceuticals (ELDN) Other financing activities (2014 - 2025)

Eledon Pharmaceuticals (ELDN) posted Other financing activities of $115000.0 for Q4 2025, little changed on a QoQ basis from $115000.0 in Q1 2025.

Eledon Pharmaceuticals (ELDN) Other financing activities (2014 - 2025) Analysis & Trends

Eledon Pharmaceuticals' Other financing activities history runs 6 years deep, the most recent figure standing at $115000.0 for Q4 2025.

Quarterly Other financing activities changed N/A year-over-year to $115000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $230000.0 (changed N/A YoY) and the FY2025 annual result came in at $230000.0, up 6.98% from the prior year.
Other financing activities was $115000.0 for Q4 2025 at Eledon Pharmaceuticals, roughly flat from $115000.0 in the prior quarter.
Across five years, Other financing activities topped out at $115000.0 in Q1 2025 and bottomed at $115000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn
7	Belite Bio	62.72 Bn	62.72 Bn	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-
10	Eledon Pharmaceuticals	399.11 Mn	399.11 Mn	-

Download Data